326 related articles for article (PubMed ID: 25038828)
1. Huntington's disease is a four-repeat tauopathy with tau nuclear rods.
Fernández-Nogales M; Cabrera JR; Santos-Galindo M; Hoozemans JJ; Ferrer I; Rozemuller AJ; Hernández F; Avila J; Lucas JJ
Nat Med; 2014 Aug; 20(8):881-5. PubMed ID: 25038828
[TBL] [Abstract][Full Text] [Related]
2. Faulty splicing and cytoskeleton abnormalities in Huntington's disease.
Fernández-Nogales M; Santos-Galindo M; Hernández IH; Cabrera JR; Lucas JJ
Brain Pathol; 2016 Nov; 26(6):772-778. PubMed ID: 27529534
[TBL] [Abstract][Full Text] [Related]
3. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
Wang Y; Wang J; Gao L; Stamm S; Andreadis A
Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
[TBL] [Abstract][Full Text] [Related]
4. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
[TBL] [Abstract][Full Text] [Related]
5. Tau-positive nuclear indentations in P301S tauopathy mice.
Fernández-Nogales M; Santos-Galindo M; Merchán-Rubira J; Hoozemans JJM; Rábano A; Ferrer I; Avila J; Hernández F; Lucas JJ
Brain Pathol; 2017 May; 27(3):314-322. PubMed ID: 27338164
[TBL] [Abstract][Full Text] [Related]
6. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice.
Umeda T; Yamashita T; Kimura T; Ohnishi K; Takuma H; Ozeki T; Takashima A; Tomiyama T; Mori H
Am J Pathol; 2013 Jul; 183(1):211-25. PubMed ID: 23680655
[TBL] [Abstract][Full Text] [Related]
7. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion.
Yin X; Jin N; Gu J; Shi J; Zhou J; Gong CX; Iqbal K; Grundke-Iqbal I; Liu F
J Biol Chem; 2012 Aug; 287(36):30497-506. PubMed ID: 22767602
[TBL] [Abstract][Full Text] [Related]
8. Regulation of alternative splicing of tau exon 10.
Qian W; Liu F
Neurosci Bull; 2014 Apr; 30(2):367-77. PubMed ID: 24627328
[TBL] [Abstract][Full Text] [Related]
9. Tau alternative splicing in familial and sporadic tauopathies.
Niblock M; Gallo JM
Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
[TBL] [Abstract][Full Text] [Related]
10. Is Huntington's disease a tauopathy?
Gratuze M; Cisbani G; Cicchetti F; Planel E
Brain; 2016 Apr; 139(Pt 4):1014-25. PubMed ID: 26969684
[TBL] [Abstract][Full Text] [Related]
11. PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.
Ray P; Kar A; Fushimi K; Havlioglu N; Chen X; Wu JY
J Mol Neurosci; 2011 Nov; 45(3):453-66. PubMed ID: 21881826
[TBL] [Abstract][Full Text] [Related]
12. Tau mis-splicing correlates with motor impairments and striatal dysfunction in a model of tauopathy.
Damianich A; Facal CL; Muñiz JA; Mininni C; Soiza-Reilly M; Ponce De León M; Urrutia L; Falasco G; Ferrario JE; Avale ME
Brain; 2021 Sep; 144(8):2302-2309. PubMed ID: 34059893
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy.
Espíndola SL; Damianich A; Alvarez RJ; Sartor M; Belforte JE; Ferrario JE; Gallo JM; Avale ME
Cell Rep; 2018 Apr; 23(3):709-715. PubMed ID: 29669277
[TBL] [Abstract][Full Text] [Related]
14. Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1.
Wang Y; Wang J; Gao L; Lafyatis R; Stamm S; Andreadis A
J Biol Chem; 2005 Apr; 280(14):14230-9. PubMed ID: 15695522
[TBL] [Abstract][Full Text] [Related]
15. Tau Isoforms: Gaining Insight into
Corsi A; Bombieri C; Valenti MT; Romanelli MG
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499709
[TBL] [Abstract][Full Text] [Related]
16. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Spillantini MG; Van Swieten JC; Goedert M
Neurogenetics; 2000 Mar; 2(4):193-205. PubMed ID: 10983715
[TBL] [Abstract][Full Text] [Related]
17. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.
Wren MC; Zhao J; Liu CC; Murray ME; Atagi Y; Davis MD; Fu Y; Okano HJ; Ogaki K; Strongosky AJ; Tacik P; Rademakers R; Ross OA; Dickson DW; Wszolek ZK; Kanekiyo T; Bu G
Mol Neurodegener; 2015 Sep; 10():46. PubMed ID: 26373282
[TBL] [Abstract][Full Text] [Related]
18. MAP2 Splicing is Altered in Huntington's Disease.
Cabrera JR; Lucas JJ
Brain Pathol; 2017 Mar; 27(2):181-189. PubMed ID: 27098187
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
[TBL] [Abstract][Full Text] [Related]
20. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
